Literature DB >> 9045933

Function of CD23 in the response of human B cells to antigen.

R Reljić1, G Cosentino, H J Gould.   

Abstract

Co-ligation of antigen receptor and complement receptor 2 (CD21) in the B cell membrane is important in the immune response to T-dependent antigens. Four CD21 ligands have so far been identified, but only the activated products of the third component of complement (C3) are known to augment the immune response to specific antigens. The most recently discovered ligand for CD21 is CD23. We have generated a CD32+ CD23+ fibroblast cell line which presents a surrogate antigen (anti-IgM) to human tonsil B cells in vitro. Incubation with these cells causes a 10- to 100-fold reduction in the threshold concentration of anti-IgM required for B cell proliferation. Anti-CD19 further enhances the response to antigen and induces proliferation in the absence of anti-IgM. Addition of soluble CD21 totally inhibits the effect of CD23, suggesting that CD21 mediates synergistic signaling by CD23.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9045933     DOI: 10.1002/eji.1830270232

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells.

Authors:  S N Karagiannis; J K Warrack; K H Jennings; P R Murdock; G Christie; K Moulder; B J Sutton; H J Gould
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

2.  Murine B cells regulate serum IgE levels in a CD23-dependent manner.

Authors:  Laurence E Cheng; Zhi-En Wang; Richard M Locksley
Journal:  J Immunol       Date:  2010-09-24       Impact factor: 5.422

3.  Expression of CD27 and CD23 on peripheral blood B lymphocytes in humans of different ages.

Authors:  Dino Veneri; Riccardo Ortolani; Massimo Franchini; Giuseppe Tridente; Giovanni Pizzolo; Antonio Vella
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

4.  Immunophenotypic profile and clinical characteristics in patients with advanced stage mantle cell lymphoma.

Authors:  M Todorovic; M Pavlovic; B Balint; N Kraguljac; B Mihaljevic; A Bogdanovic; I Elezovic; D Boskovic; M Colovic
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

5.  Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.

Authors:  F Mensah; A Bansal; S Berkovitz; A Sharma; V Reddy; M J Leandro; G Cambridge
Journal:  Clin Exp Immunol       Date:  2016-02-22       Impact factor: 4.330

6.  Soluble CD23 controls IgE synthesis and homeostasis in human B cells.

Authors:  Alison M Cooper; Philip S Hobson; Mark R Jutton; Michael W Kao; Binia Drung; Boris Schmidt; David J Fear; Andrew J Beavil; James M McDonnell; Brian J Sutton; Hannah J Gould
Journal:  J Immunol       Date:  2012-03-05       Impact factor: 5.422

7.  Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis.

Authors:  Anjana Singh; Sebastiaan J Vastert; Berent J Prakken; Harald Illges
Journal:  Rheumatol Int       Date:  2011-02-17       Impact factor: 3.580

8.  The structure of human CD23 and its interactions with IgE and CD21.

Authors:  Richard G Hibbert; Peter Teriete; Gabrielle J Grundy; Rebecca L Beavil; Rajko Reljic; V Michael Holers; Jonathan P Hannan; Brian J Sutton; Hannah J Gould; James M McDonnell
Journal:  J Exp Med       Date:  2005-09-19       Impact factor: 14.307

9.  LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation.

Authors:  Alba Llibre; Constantino López-Macías; Teresa Marafioti; Hema Mehta; Amy Partridge; Carina Kanzig; Felice Rivellese; Jacob D Galson; Lucy J Walker; Paul Milne; Rodney E Phillips; Dominic F Kelly; Gordon J Freeman; Mohey Eldin El Shikh; Paul Klenerman; Christian B Willberg
Journal:  J Immunol       Date:  2016-02-01       Impact factor: 5.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.